CycB/CCNB1 Cancer Research Results

CycB/CCNB1, Cyclin B: Click to Expand ⟱
Source:
Type:
When cyclin B levels are elevated, cells can enter M phase prematurely and strict control over cell division is lost, which is favorable for cancer development.
Cyclin B is a regulatory protein that plays a crucial role in cell cycle progression, particularly in the transition from the G2 phase to mitosis. Its expression levels can significantly impact cancer progression and patient prognosis.
Cyclin B expression is often elevated in various cancers and is generally associated with poor prognosis.
Cyclin B levels:
-Accumulate during S and G2
-Peak at mitotic entry
-Are rapidly destroyed at metaphase–anaphase transition via the APC/C ubiquitin ligase


Scientific Papers found: Click to Expand⟱
913- QC,    Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression
- in-vitro, BC, SkBr3 - in-vitro, BC, MDA-MB-435
TumCP↓, TumCCA↑, DNAdam↑, Chk2↑, CycB/CCNB1↓, CDK1↓, tumCV↓, p‑RB1↓, P21↑,
3054- RES,    Resveratrol induced reactive oxygen species and endoplasmic reticulum stress-mediated apoptosis, and cell cycle arrest in the A375SM malignant melanoma cell line
- in-vitro, Melanoma, A375
TumCG↓, P21↑, p27/CDKN1B↑, CycB/CCNB1↓, ROS↑, ER Stress↑, p‑p38↑, P53↑, p‑eIF2α↑, EP4/PTGER4↑, CHOP/DDIT3↑, Bcl-2↓, BAX↓, TumCCA↑, NRF2↓, ChemoSen↑, GSH↓,
7951- RT,  BuckWS,    The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives
- Review, Nor, NA
*Dose↝, *BioAv↓, *BioAv↓, *BioAv↓, *BioAv↓, *BioAv↝, TumCP↓, Risk↓, *radioP↑, chemoPv↑, TumCCA↑, GSK‐3β↑, Wnt↓, β-catenin/ZEB1↓, ROS↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, PARP↑, Beclin-1/ATG6↑, ATG5↑, LC3II↑, DNMT1↓, P21↑, CDK1↑, CycB/CCNB1↓, TNF-α↑, VEGF↓, IL1β↓, NF-kB↓, AP-1↓, MYCN↓, AMPK↑, MAPK↓, PI3K↓, Akt↓, cMET↓, P-gp/ABCB1↓, MRP1/ABCC1↓, ABCG2↓, MMPs↓, TNF-α↓, iNOS↓, COX2/PTGS2↓, angioG↓, STAT3↓, *chemoP↑, *ROS↓, *MDA↓, *P53↓, *Casp3↓, *Casp9↓, *JNK↓, *TNF-α↓, *p38↓, *MAPK↓, GSH↓, ChemoSen↑, *hepatoP↑, *COX1↓, *COX2/PTGS2↓, *15-LOX/ALOX15↓, RenoP↑, *toxicity↓,
1471- SFN,    ROS-mediated activation of AMPK plays a critical role in sulforaphane-induced apoptosis and mitotic arrest in AGS human gastric cancer cells
- in-vitro, GC, AGS
TumCP↓, Apoptosis↑, TumCCA↑, CycB/CCNB1↑, P21↑, p‑H3↑, p‑AMPK↑, eff↓, MMP↓, Cyt‑c↑, ROS↑, eff↓,
1463- SFN,    Sulforaphane induces reactive oxygen species-mediated mitotic arrest and subsequent apoptosis in human bladder cancer 5637 cells
- in-vitro, Bladder, 5637
tumCV↓, CycB/CCNB1↑, p‑CDK1↑, Apoptosis↑, Casp8↑, Casp9↑, Casp3↑, cl‑PARP↑, ROS↑, eff↓,
1480- SFN,    Sulforaphane Induces Cell Death Through G2/M Phase Arrest and Triggers Apoptosis in HCT 116 Human Colon Cancer Cells
- in-vitro, CRC, HCT116
tumCV↓, TumCCA↑, Apoptosis↑, cycA1/CCNA1↑, CycB/CCNB1↑, CDC25↓, CDK1↓, ROS↑, eff↓, Cyt‑c↑, AIF↑, ER Stress↑,
1726- SFN,    Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential
- Review, Var, NA
Dose↝, eff↝, IL1β↓, IL6↓, IL12↓, TNF-α↓, COX2/PTGS2↓, CXCR4↓, MPO↓, HSP70/HSPA5↓, HSP90↓, VCAM-1↓, IKKα↓, NF-kB↓, HO-1↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, cl‑PARP↑, Cyt‑c↑, Diablo↑, CHOP/DDIT3↑, survivin↓, XIAP↓, p38↑, Fas↑, PUMA↑, VEGF↓, Hif1a↓, Twist↓, Zeb1↓, Vim↓, MMP2↓, MMP9↓, E-cadherin↑, N-cadherin↓, Snail↓, CD44↓, cycD1/CCND1↓, cycA1/CCNA1↓, CycB/CCNB1↓, cycE/CCNE↓, CDK4↓, CDK6↓, p50↓, P53↑, P21↑, GSH↑, SOD↑, GSTs↑, mTOR↓, Akt↓, PI3K↓, β-catenin/ZEB1↓, IGF-1↓, cMyc↓, CSCs↓,
3301- SIL,    Critical review of therapeutic potential of silymarin in cancer: A bioactive polyphenolic flavonoid
- Review, Var, NA
Inflam↓, TumCCA↑, Apoptosis↓, TumMeta↓, TumCG↓, angioG↓, chemoP↑, radioP↑, p‑ERK↓, p‑p38↓, p‑JNK↓, P53↑, Bcl-2↓, Bcl-xL↓, TGF-β↓, MMP2↓, MMP9↓, E-cadherin↑, Wnt↓, Vim↓, VEGF↓, IL6↓, STAT3↓, *ROS↓, IL1β↓, PGE2↓, CDK1↓, CycB/CCNB1↓, survivin↓, Mcl-1↓, Casp3↑, Casp9↑, cMyc↓, COX2/PTGS2↓, Hif1a↓, CXCR4↓, CSCs↓, EMT↓, N-cadherin↓, PCNA↓, cycD1/CCND1↓, ROS↑, Synergy↑, Synergy↑, Synergy↑, HER2/EBBR2↓,
3289- SIL,    Silymarin: a promising modulator of apoptosis and survival signaling in cancer
- Review, Var, NA
*BioAv↝, *BioAv↓, Fas↑, FasL↑, FADD↑, pro‑Casp8↑, Apoptosis↑, DR5↑, Bcl-2↑, BAX↑, Casp3↑, PI3K↓, FOXM1↓, p‑mTOR↓, p‑P70S6K↓, Hif1a↓, Akt↑, angioG↓, STAT3↓, NF-kB↓, lipid-P↓, Synergy↑, CDK1↓, survivin↓, CycB/CCNB1↓, Mcl-1↓, Casp9↑, AP-1↓, BioAv↑,
3415- TQ,    The anti-neoplastic impact of thymoquinone from Nigella sativa on small cell lung cancer: In vitro and in vivo investigations
- in-vitro, Lung, H446
tumCV↓, TumCCA↑, ROS↓, CycB/CCNB1↑, CycD3↑, cycA1/CCNA1↓, cycE/CCNE↓, cDC2↓, antiOx↑, PARP↓, NRF2↓, ARE/EpRE↑, eff↓,
7887- VT,  IVT,    Dietary Flavonoids Vitexin and Isovitexin: New Insights into Their Functional Roles in Human Health and Disease Prevention
- Review, AD, NA - Review, Var, NA
*antiOx↑, *Inflam↓, *AntiCan↑, *Bacteria↓, *neuroP↑, *Obesity↓, *cardioP↑, *ROS↓, *MMP↑, *ATP↑, *MFN2↑, *DRP1/DNM1L↓, *FOXO3↑, *NRF2↑, *Ferroptosis↓, *GPx4↑, TumCP↓, HMGB1↓, PI3K↓, Akt↓, Hif1a↓, CDK1↓, CycB/CCNB1↓, TumCCA↑, Apoptosis↑, P53↑, NF-kB↓, ERK↓, p‑PI3K↓, miR-34a↑, Apoptosis↑, CSCs?, *MAPK↓, *HO-1↑, *hepatoP↑, *AMPK↑, *Akt↑, *GSK‐3β↑, *chemoP↑, *Casp3↓, *IRes↝, *GlucoseCon↑, ChemoSen↑, *GSH↑, *SOD↑, *ATF2↑, *GPx↑, *GSTs↑, *AntiAge↑, *Stroke↓, *AChE↓, *ACE/ACE1↓, *ACE2↓, *GutMicro↑, *MPO↓, *H+/K+-ATPase↓, *AntiDiabetic↑, *GLUT4↑, *Obesity↓, *HH↓, *RenoP↑, *BioAv↓, *BioAv↝, *BioAv↑,

Showing Research Papers: 101 to 111 of 111
Prev Page 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 111

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 3,   ARE/EpRE↑, 1,   Catalase↓, 1,   Fenton↑, 1,   GPx↑, 1,   GPx4↓, 2,   GSH↓, 9,   GSH↑, 2,   GSR↑, 1,   GSTs↑, 2,   HO-1↓, 1,   HO-1↑, 3,   Iron↓, 1,   Iron↑, 1,   i-Iron↑, 1,   lipid-P↓, 3,   lipid-P↑, 6,   MDA↓, 1,   MDA↑, 1,   MPO↓, 1,   NQO1↓, 1,   NQO1↑, 3,   NRF2↓, 7,   NRF2↑, 5,   ROS?, 1,   ROS↓, 10,   ROS↑, 57,   ROS⇅, 2,   ROS∅, 2,   i-ROS↑, 1,   mt-ROS↑, 1,   SOD↓, 1,   SOD↑, 4,   SOD1↑, 1,   SOD2↑, 1,   Trx↓, 1,   Trx1↑, 1,   TrxR↓, 1,   TrxR1↓, 1,   xCT/SLC7A11↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 11,   CDC2↑, 1,   CDC25↓, 20,   CDC25↑, 1,   CDC25↝, 1,   compI↓, 1,   compIII↓, 2,   compV↓, 1,   EGF↓, 2,   ETC↓, 1,   mitResp↓, 1,   mtDam↑, 3,   OXPHOS↓, 2,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 2,   ACC↑, 1,   ALDOA↓, 1,   AMPK↓, 1,   AMPK↑, 7,   p‑AMPK↑, 2,   ATP↓, 2,   mt-ATP↓, 1,   CAIX/CA9↑, 1,   ENO1↓, 1,   GlucoseCon↓, 2,   GlucoseCon∅, 1,   Glycolysis↓, 5,   GSK‐3β↓, 3,   GSK‐3β↑, 3,   p‑GSK‐3β↓, 2,   H2S↑, 1,   HK1↓, 1,   HK2↓, 5,   lactateProd↓, 3,   lactateProd∅, 1,   LDHA↓, 3,   MCT4↓, 1,   NADPH↑, 1,   PDK1 / PDPK1↓, 3,   PDK3↑, 1,   PFK↓, 1,   PKM2↓, 2,   p‑S6↓, 1,   TCA↓, 1,   Warburg↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 4,   APAF1↑, 7,   Apoptosis↓, 2,   Apoptosis↑, 65,   mt-Apoptosis↑, 1,   BAD↓, 1,   BAD↑, 5,   Bak↑, 2,   BAX↓, 2,   BAX↑, 44,   Bax:Bcl2↑, 5,   Bcl-2↓, 47,   Bcl-2↑, 2,   Bcl-xL↓, 15,   BID↑, 1,   BIM↑, 1,   BNIP3↑, 1,   BOK↑, 1,   Casp↓, 1,   Casp↑, 5,   Casp10↑, 2,   Casp12↑, 1,   Casp3↓, 3,   Casp3↑, 40,   cl‑Casp3↑, 12,   proCasp3↓, 1,   Casp7↑, 9,   Casp8↑, 13,   cl‑Casp8↑, 4,   proCasp8↓, 1,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 34,   cl‑Casp9↑, 4,   proCasp9↓, 2,   cFLIP↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 24,   Diablo↑, 2,   DR5↓, 1,   DR5↑, 10,   FADD↑, 3,   Fas↑, 9,   FasL↑, 6,   Ferroptosis↑, 3,   HEY1↓, 1,   IAP1↓, 2,   iNOS↓, 5,   Mcl-1↓, 7,   MDM2↓, 9,   MOMP↑, 2,   NAIP↓, 1,   p38↑, 6,   p‑p38↓, 1,   p‑p38↑, 3,   PUMA↓, 1,   PUMA↑, 3,   survivin↓, 16,   TRAIL↑, 2,   TumCD↓, 1,   TumCD↑, 8,   XIAP↓, 5,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 38,   Akt↑, 2,   p‑Akt↓, 13,   AKT1↓, 1,   cMET↓, 2,   p‑cMET↑, 1,   p‑CREB↓, 1,   EGFR↓, 6,   p‑EGFR↓, 1,   ERK↓, 13,   ERK↑, 2,   p‑ERK↓, 7,   p‑ERK↑, 1,   FGFR1↓, 1,   HER2/EBBR2↓, 2,   p‑HER2/EBBR2↓, 1,   IGF-1R↓, 1,   IKKα↓, 3,   p‑IKKα↓, 1,   IκB↑, 1,   JAK1↓, 1,   JAK1↑, 1,   JAK2↓, 3,   JNK↓, 1,   JNK↑, 7,   p‑JNK↓, 1,   p‑JNK↑, 2,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 10,   MAPK↑, 5,   p‑MAPK↓, 1,   mTOR↓, 23,   mTOR↑, 1,   p‑mTOR↓, 5,   mTORC2↓, 1,   p70S6↑, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   p‑P90RSK↑, 1,   PDGFR-BB↓, 1,   PI3K↓, 32,   PI3K↑, 1,   p‑PI3K↓, 2,   PI3K/Akt↓, 1,   PI3k/Akt/mTOR↓, 1,   PKCδ↓, 6,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↓, 1,   PTEN↑, 3,   Raf↓, 2,   RAS↓, 4,   RSK2/RPS6KA3/p90RSK2↓, 1,   Sp1/3/4↓, 3,   STAT↓, 1,   STAT3↓, 20,   STAT3↑, 1,   p‑STAT3↓, 2,   p‑STAT3↑, 1,   STAT5↓, 1,   STK11/LKB1↑, 1,   p‑STK11/LKB1↑, 1,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF1↓, 1,   ATF3↑, 1,   ATF4↑, 5,   CBP↓, 1,   p‑cJun↑, 1,   cMyc↓, 13,   p‑cMyc↑, 1,   DNMT1↓, 1,   DNMTs↓, 1,   EZH2↓, 4,   FOXM1↓, 5,   FOXO1↓, 1,   FOXO3↓, 1,   FOXO3↑, 1,   p‑FOXO3↓, 1,   H3↓, 3,   H3↑, 1,   p‑H3↑, 1,   ac‑H3↑, 1,   H3K27ac↓, 1,   HATs↓, 2,   HDAC↓, 5,   HDAC10↓, 1,   HDAC6↓, 1,   HMTs↓, 1,   miR-107↑, 1,   miR-139-5p↑, 1,   miR-155↓, 1,   miR-21↓, 3,   miR-21↑, 1,   miR-224↓, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 2,   miR-384↑, 1,   miR-422a↑, 1,   MTA2↓, 1,   MYCN↓, 1,   OCT4↓, 2,   other↓, 1,   other↝, 2,   PhotoS↑, 2,   sonoS↑, 1,   SOX2↓, 3,   SOX4↓, 1,   tumCV↓, 14,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 1,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 10,   eIF2α↓, 1,   eIF2α↑, 2,   p‑eIF2α↑, 3,   ER Stress↓, 1,   ER Stress↑, 14,   GRP78/BiP↓, 1,   GRP78/BiP↑, 5,   GRP94↑, 1,   HSP70/HSPA5↓, 3,   HSP90↓, 5,   PERK↑, 2,   UPR↑, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 1,   ATG5↑, 2,   ATG7↑, 1,   Beclin-1/ATG6↑, 6,   CTSK↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3B-II↑, 2,   LC3II↑, 3,   p62↑, 2,   RUBCN↓, 1,   TumAuto↑, 10,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1,   DFF45↓, 1,   DNAdam↑, 13,   DNArepair↓, 3,   DNArepair↑, 1,   ERCC3↑, 1,   hTERT/TERT↓, 3,   P53↓, 2,   P53↑, 37,   p‑P53↓, 1,   p‑P53↑, 1,   PARP↓, 5,   PARP↑, 10,   cl‑PARP↑, 22,   PCNA↓, 11,   PCNA↝, 1,   Telomerase↓, 3,   TOP1↓, 1,   TOP2↓, 3,   TOP2↑, 1,   XRCC1↓, 1,   γH2AX↑, 3,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 38,   CDK1↑, 2,   CDK1↝, 1,   p‑CDK1↓, 1,   p‑CDK1↑, 1,   CDK2↓, 22,   CDK2↑, 1,   p‑CDK2↓, 1,   CDK4↓, 21,   CDK4/6↓, 1,   CDK6↓, 4,   CHK1↓, 2,   CHK1↑, 1,   CHK1↝, 1,   p‑CHK1↑, 1,   Chk2↓, 2,   Chk2↑, 3,   Cyc↓, 1,   cycA1/CCNA1↓, 19,   cycA1/CCNA1↑, 3,   CycB/CCNB1↓, 93,   CycB/CCNB1↑, 16,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 30,   cycD1/CCND1↑, 2,   CycD3↓, 1,   CycD3↑, 1,   cycE/CCNE↓, 13,   cycE1↓, 1,   E2Fs↓, 3,   Ki-67↓, 6,   mitA↑, 1,   P21↓, 3,   P21↑, 41,   p27/CDKN1B↓, 3,   p27/CDKN1B↑, 13,   pRB↓, 1,   pRB↑, 1,   p‑pRB↓, 1,   RB1↓, 1,   RB1↑, 1,   p‑RB1↓, 2,   TumCCA↓, 3,   TumCCA↑, 91,   WEE1↑, 3,   β-Tubulin↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   ALDH1A1↓, 1,   BMI1↓, 1,   CD133↓, 2,   cFos↓, 2,   CSCs?, 1,   CSCs↓, 9,   EP4/PTGER4↑, 1,   FGF↓, 2,   Gli1↓, 1,   HH↓, 1,   IGF-1↓, 1,   IGFBP3↑, 1,   Ki-67↓, 6,   Let-7↓, 1,   Nanog↓, 4,   NICD↓, 1,   NOTCH↓, 5,   NOTCH1↓, 3,   NOTCH1↑, 1,   p300↓, 1,   Shh↓, 3,   Smo↓, 1,   TAZ↓, 1,   TumCG↓, 22,   TumCG↑, 1,   TumCP?, 1,   TumCP↓, 48,   TumCP↑, 1,   Wnt↓, 9,   Wnt/(β-catenin)↓, 2,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AEG1↑, 1,   AP-1↓, 4,   Ca+2↑, 8,   i-Ca+2↑, 1,   Cal1↑, 1,   cal2↑, 1,   Cdc42↑, 1,   E-cadherin↑, 13,   E-cadherin↝, 1,   EMT↓, 16,   EMT↑, 1,   FAK↓, 4,   p‑FAK↓, 2,   KRAS↓, 1,   MMP-10↓, 1,   MMP1↓, 1,   MMP13↓, 2,   MMP16↓, 1,   MMP2↓, 19,   MMP3↓, 4,   MMP7↓, 1,   MMP9↓, 19,   MMP9↑, 2,   MMPs↓, 9,   N-cadherin↓, 9,   N-cadherin↝, 1,   pax↓, 1,   PDGF↓, 2,   Rho↓, 2,   ROCK1↓, 3,   Slug↓, 5,   Snail↓, 6,   TGF-β↓, 5,   TIMP1↓, 1,   TIMP1↑, 4,   TIMP2↑, 3,   TSC1↑, 1,   TSP-1↑, 1,   TumCI↓, 18,   TumCMig↓, 13,   TumMeta↓, 12,   TumMeta↑, 1,   Twist↓, 4,   uPA↓, 6,   uPAR↓, 2,   Vim↓, 11,   Zeb1↓, 3,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 6,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 21,   Endoglin↑, 1,   HIF-1↓, 2,   Hif1a↓, 11,   LOX1↓, 1,   NO↓, 1,   NO↑, 1,   VCAM-1↓, 1,   VEGF↓, 23,   VEGFR2/KDR/Flk1↓, 4,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 2,   CellMemb↑, 1,   CLDN2↓, 1,   GLUT1↓, 4,   GLUT1↑, 1,   GLUT3↑, 1,   GLUT4↓, 2,   MMP↓, 29,   TRPV1↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD4+↓, 1,   CD4+↑, 1,   CD44↓, 3,   cDC2↓, 7,   p‑cDC2↓, 1,   COX2/PTGS2↓, 19,   COX2/PTGS2↑, 1,   CXCR4↓, 6,   Eos↑, 1,   FOXP3↓, 1,   HMGB1↓, 2,   ICAM-1↓, 1,   IFN-γ↓, 1,   Igs↑, 1,   IL1↓, 3,   IL10↓, 2,   IL12↓, 1,   IL1α↓, 1,   IL1β↓, 7,   IL2↓, 2,   IL2↑, 1,   IL6↓, 12,   IL8↓, 4,   Imm↑, 4,   Inflam↓, 7,   Inflam↝, 1,   IRAK1↓, 1,   MCP1/CCL2↓, 1,   MCT1↓, 1,   mPGES-1↓, 1,   Neut↑, 1,   NF-kB↓, 33,   NF-kB↑, 1,   p‑NF-kB↓, 1,   p‑NF-kB↑, 1,   NK cell↑, 2,   p50↓, 1,   ac‑p65↓, 1,   PD-L1↓, 3,   PGE2↓, 4,   PSA↓, 3,   SOCS-3↓, 1,   T-Cell↑, 1,   Th1 response↑, 1,   TLR4↓, 2,   TNF-α↓, 12,   TNF-α↑, 3,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 3,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GGT/CD224↑, 1,   pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

PTN↓, 1,  

Protein Aggregation(tgid=19) ⓘ

APOE4↑, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 1,   AR↓, 5,   ER-α36↓, 1,   ER(estro)↓, 1,   PPARα↑, 1,   PPARγ↑, 2,   RANKL↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   BioAv↓, 8,   BioAv↑, 12,   BioAv↝, 2,   BioEnh↑, 1,   ChemoSen↓, 1,   ChemoSen↑, 32,   CompStab↑, 1,   CompStab↝, 1,   Dose?, 1,   Dose↝, 5,   Dose∅, 1,   eff↓, 19,   eff↑, 12,   eff↝, 2,   GSTA1↓, 1,   Half-Life↓, 4,   Half-Life↑, 1,   MDR1↓, 3,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 4,   P-gp/ABCB1∅, 1,   RadioS↑, 13,   selectivity↑, 21,   Synergy↑, 20,  

Clinical Biomarkers(tgid=22) ⓘ

AR↓, 5,   CRP↓, 1,   E6↓, 2,   E7↓, 2,   EGFR↓, 6,   p‑EGFR↓, 1,   EZH2↓, 4,   FOXM1↓, 5,   HER2/EBBR2↓, 2,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6↓, 12,   KRAS↓, 1,   LDH↑, 1,   PD-L1↓, 3,   PSA↓, 3,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 9,   AntiTum↑, 4,   cardioP↑, 3,   chemoP↑, 3,   chemoPv↑, 4,   ChemoSideEff↓, 1,   hepatoP↑, 1,   OS↑, 1,   radioP↑, 4,   RenoP↑, 3,   Risk↓, 4,   toxicity↓, 6,   TumVol↓, 6,   TumW↓, 3,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 2,   GutMicro↑, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 577

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 14,   Catalase↑, 6,   GPx↑, 5,   GPx4↑, 1,   GSH↑, 8,   GSR↑, 1,   GSTs↑, 4,   HO-1↑, 3,   Keap1↓, 1,   lipid-P↓, 8,   MDA↓, 4,   MPO↓, 2,   Nrf1↑, 1,   NRF2↑, 7,   Prx↑, 1,   RNS↓, 1,   ROS↓, 21,   ROS↑, 1,   SOD↓, 1,   SOD↑, 7,   SOD2↑, 1,   TBARS↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↓, 1,   IronCh↑, 2,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

DRP1/DNM1L↓, 1,   MFN2↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   ACSL4↓, 1,   ALAT↓, 1,   AMPK↑, 3,   ATP↑, 1,   FASN↓, 1,   glucose↓, 1,   GlucoseCon↑, 1,   GSK‐3β↓, 1,   GSK‐3β↑, 1,   H2S↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 1,   BAX↑, 1,   Bcl-2↓, 1,   Casp3?, 1,   Casp3↓, 2,   cl‑Casp8↑, 1,   Casp9↓, 1,   Cyt‑c↑, 1,   Ferroptosis↓, 2,   iNOS↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   Akt↑, 2,   JAK↓, 1,   JNK↓, 1,   MAPK↓, 2,   mTOR↑, 1,   PI3K↓, 1,   PI3K↑, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↑, 1,   FOXO3↑, 1,   other↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   P53↓, 1,   P53↑, 1,   PARP↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 1,   CycB/CCNB1↓, 1,   P21↑, 2,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

HH↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 2,   TregCell↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   NO↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 2,   BBB↑, 2,   GastroP↑, 1,   GLUT4↑, 1,   H+/K+-ATPase↓, 1,   MMP↓, 1,   MMP↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX1↓, 1,   COX2/PTGS2↓, 4,   IL10↓, 1,   IL17↓, 1,   IL1β↓, 1,   IL6↓, 2,   IL8↓, 1,   Inflam↓, 14,   MCP1/CCL2↓, 1,   NF-kB↓, 2,   NK cell↑, 1,   PGE2↓, 1,   TNF-α↓, 3,   β-HEX↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 3,   MAOA↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 3,   tau↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE2↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 11,   BioAv↑, 9,   BioAv↝, 8,   Dose↝, 1,   eff↑, 1,   Half-Life↑, 1,   Half-Life↝, 3,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   AST↓, 1,   BP↓, 2,   creat↓, 1,   IL6↓, 2,   IRes↝, 1,   LDH↓, 2,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   antiAll↑, 2,   AntiCan↑, 3,   AntiDiabetic↑, 5,   AntiTum↓, 2,   cardioP↑, 6,   chemoP↑, 3,   cognitive↑, 1,   diuretic↑, 1,   hepatoP↑, 9,   memory↑, 1,   Mucositis↓, 1,   neuroP↑, 13,   Obesity↓, 4,   Pain↓, 1,   radioP↑, 2,   RenoP↑, 1,   Stroke↓, 1,   toxicity↓, 4,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   GutMicro↑, 3,  
Total Targets: 141

Scientific Paper Hit Count for: CycB/CCNB1, Cyclin B
10 Quercetin
4 Propolis -bee glue
4 Licochalcone A
4 Sulforaphane (mainly Broccoli)
3 Allyl isothiocyanate
3 Allicin (mainly Garlic)
3 Apigenin (mainly Parsley)
3 Benzyl isothiocyanate
3 Eugenol
3 Cucurbitacin
3 Curcumin
3 Emodin
3 Luteolin
3 Magnolol
3 Plumbagin
2 Ashwagandha(Withaferin A)
2 Baicalein
2 Betulinic acid
2 Chrysin
2 D-limonene
2 Fenbendazole
2 Formononetin
2 Garcinol
2 Isoliquiritigenin
2 Isorhamnetin
2 Kaempferol
2 lambertianic acid
2 Magnetic Fields
2 Morin
2 doxorubicin
2 Silymarin (Milk Thistle) silibinin
1 Cisplatin
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Andrographis
1 Artemisinin
1 Astaxanthin
1 Aloe anthraquinones
1 Berberine
1 Biochanin A
1 Bufalin/Huachansu
1 Phenethyl isothiocyanate
1 Isothiocyanates
1 Chlorophyllin
1 Cinnamon
1 Crocetin
1 Radiotherapy/Radiation
1 Diindolylmethane
1 tamoxifen
1 Fisetin
1 Genistein (soy isoflavone)
1 isoflavones
1 isoorientin
1 Juglone
1 Laetrile B17 Amygdalin
1 Lapachol
1 SDG/lignans
1 Lycopene
1 Mangiferin
1 Melatonin
1 Phenylbutyrate
1 Piperlongumine
1 Resveratrol
1 Rutin
1 buckwheat sprouts
1 Thymoquinone
1 Vitexin
1 Isovitexin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:379  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page